Systematic review of active surveillance for clinically localized prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy

Willemse, P-P M, Davis, N F, Grivas, N, Zattoni, F, Lardas, M, Briers, E, Cumberbatch, M G, De Santis, M, Dell'Oglio, P, Donaldson, J F, Fossati, N, Gandaglia, G, Gillessen, S, Grummet, J P, Henry, A M, Liew, M, MacLennan, S, Mason, M D, Moris, L, Plass, K, O'Hanlon, S, Omar, M I, Oprea-Lager, D E, Pang, K H, Paterson, C, Ploussard, G, Rouvière, O, Schoots, I G, Tilki, D, van den Bergh, R C N, van den Broeck, T, van der Kwast, T H, van der Poel, H G, Wiegel, T, Yuan, C Y, Cornford, P, Mottet, N & Lam, T B L 2022, 'Systematic review of active surveillance for clinically localized prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy', European Urology, vol. 81, no. 4, pp. 337-346. https://doi.org/10.1016/j.eururo.2021.12.007